PL323993A1 - Method of obtaining n-monosubstituted and n,n-disubstituted dissymmetrical cyclic ureas - Google Patents

Method of obtaining n-monosubstituted and n,n-disubstituted dissymmetrical cyclic ureas

Info

Publication number
PL323993A1
PL323993A1 PL96323993A PL32399396A PL323993A1 PL 323993 A1 PL323993 A1 PL 323993A1 PL 96323993 A PL96323993 A PL 96323993A PL 32399396 A PL32399396 A PL 32399396A PL 323993 A1 PL323993 A1 PL 323993A1
Authority
PL
Poland
Prior art keywords
dissymmetrical
monosubstituted
disubstituted
obtaining
cyclic ureas
Prior art date
Application number
PL96323993A
Other languages
English (en)
Inventor
James David Rodgers
Jung-Hui Sun
Original Assignee
Du Pont Merck Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Du Pont Merck Pharma filed Critical Du Pont Merck Pharma
Publication of PL323993A1 publication Critical patent/PL323993A1/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/06—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D243/00—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms
    • C07D243/04—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms having the nitrogen atoms in positions 1 and 3
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/04—Ortho-condensed systems
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pyridine Compounds (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
PL96323993A 1995-06-07 1996-06-06 Method of obtaining n-monosubstituted and n,n-disubstituted dissymmetrical cyclic ureas PL323993A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US08/481,683 US5532357A (en) 1995-06-07 1995-06-07 Method for preparing N-monosubstituted and N,N'-disubstituted unsymmetrical cyclic ureas

Publications (1)

Publication Number Publication Date
PL323993A1 true PL323993A1 (en) 1998-04-27

Family

ID=23912954

Family Applications (1)

Application Number Title Priority Date Filing Date
PL96323993A PL323993A1 (en) 1995-06-07 1996-06-06 Method of obtaining n-monosubstituted and n,n-disubstituted dissymmetrical cyclic ureas

Country Status (26)

Country Link
US (1) US5532357A (cs)
EP (2) EP0837855A4 (cs)
JP (1) JPH11506779A (cs)
KR (1) KR19990022467A (cs)
CN (1) CN1192209A (cs)
AR (1) AR002384A1 (cs)
AU (1) AU704535B2 (cs)
BR (1) BR9609493A (cs)
CA (1) CA2223391A1 (cs)
CZ (1) CZ381997A3 (cs)
EA (1) EA000363B1 (cs)
EE (1) EE9700330A (cs)
HR (1) HRP960259A2 (cs)
HU (1) HUP9900913A2 (cs)
IL (1) IL122424A0 (cs)
LT (1) LT4381B (cs)
LV (1) LV12045B (cs)
MX (1) MX9709652A (cs)
NO (1) NO975679L (cs)
NZ (1) NZ309648A (cs)
PL (1) PL323993A1 (cs)
SI (1) SI9620077A (cs)
SK (1) SK164397A3 (cs)
TW (1) TW358091B (cs)
WO (1) WO1996040652A1 (cs)
ZA (1) ZA964847B (cs)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5466797A (en) * 1994-06-30 1995-11-14 The Du Pont Merck Pharmaceutical Company Intermediates for the preparation of cyclic urea
US6054597A (en) * 1995-11-14 2000-04-25 Dupont Pharmaceuticals Processes and intermediates for the preparation of cyclic urea HIV protease inhibitors
CA2270966A1 (en) * 1996-11-08 1998-05-14 Du Pont Pharmaceuticals Company 1-(3-aminoindazol-5-yl)-3-phenylmethyl-cyclic ureas useful as hiv protease inhibitors
US5932570A (en) * 1996-11-08 1999-08-03 Dupont Pharmaceuticals Company 1-(3-aminoindazol-5-yl)-3-phenylmethyl-cyclic ureas useful as HIV protease inhibitors
US6218386B1 (en) 1996-11-08 2001-04-17 Dupont Pharmaceuticals A1-(3-aminoindazol-5-yl)-3 butyl-cyclic urea useful as a HIV protease inhibitor
WO1998043969A1 (en) * 1997-03-31 1998-10-08 Dupont Pharmaceuticals Company Indazoles of cyclic ureas useful as hiv protease inhibitors
US6218534B1 (en) 1997-10-06 2001-04-17 Dupont Pharmaceuticals Company Preparation of asymmetric cyclic ureas through a monoacylated diamine intermediate
EP1091944A1 (en) 1998-06-30 2001-04-18 Du Pont Pharmaceuticals Company 1,3-benzodiazepin-2-ones and 1,3-benzoxazepin-2-ones useful as hiv reverse transcriptase inhibitors
EP1183242A2 (en) 1999-05-26 2002-03-06 Du Pont Pharmaceuticals Company 1,4-benzodiazepin-2-ones useful as hiv reverse transcriptase inhibitors
US6313110B1 (en) * 1999-06-02 2001-11-06 Dupont Pharmaceuticals Company Substituted 2H-1,3-diazapin-2-one useful as an HIV protease inhibitor
FR2810039B1 (fr) * 2000-06-13 2007-05-25 Centre Nat Rech Scient Composes urees cycliques et leur procede de preparation
WO2002078628A2 (en) * 2001-03-28 2002-10-10 Bristol-Myers Squibb Company Cyanamide, alkoxyamino, and urea derivatives of 1,3-benzodiazapines as hiv reverse transcriptase inhibitors
US7777030B2 (en) * 2005-12-29 2010-08-17 Centre National de la Recherge Scientifique (CNRS) Compositions and methods for the treatment and prevention of disease

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5610294A (en) * 1991-10-11 1997-03-11 The Du Pont Merck Pharmaceutical Company Substituted cyclic carbonyls and derivatives thereof useful as retroviral protease inhibitors
EP0607334B1 (en) * 1991-10-11 1997-07-30 The Du Pont Merck Pharmaceutical Company Cyclic ureas and analogues useful as retroviral protease inhibitiors
US5430043A (en) * 1993-08-24 1995-07-04 G. D. Searle & Co. Platelet aggregation inhibitors
US5466797A (en) * 1994-06-30 1995-11-14 The Du Pont Merck Pharmaceutical Company Intermediates for the preparation of cyclic urea
US5530124A (en) * 1994-06-30 1996-06-25 The Dupont Merck Pharmaceutical Company Method for preparing cyclic ureas and their use for the synthesis of HIV protease inhibitors
US5532356A (en) * 1995-06-06 1996-07-02 The Dupont Merck Pharmaceutical Company Method for preparing N,N'-disubstituted cyclic ureas
US7344671B2 (en) 2003-11-26 2008-03-18 Glopak Inc. Optical sealing clamp and a method for sealing and cutting polymeric sheets with a laser
US7369013B2 (en) 2005-04-06 2008-05-06 Avago Technologies Wireless Ip Pte Ltd Acoustic resonator performance enhancement using filled recessed region

Also Published As

Publication number Publication date
ZA964847B (en) 1997-12-08
CZ381997A3 (cs) 1999-01-13
KR19990022467A (ko) 1999-03-25
EP1029859A1 (en) 2000-08-23
LT97188A (en) 1998-04-27
EA000363B1 (ru) 1999-06-24
NO975679D0 (no) 1997-12-05
HRP960259A2 (en) 1997-10-31
AU5986896A (en) 1996-12-30
JPH11506779A (ja) 1999-06-15
EP0837855A4 (en) 1998-09-02
AR002384A1 (es) 1998-03-11
EA199800034A1 (ru) 1998-08-27
BR9609493A (pt) 1999-03-02
LV12045B (en) 1998-09-20
CN1192209A (zh) 1998-09-02
NO975679L (no) 1998-02-02
US5532357A (en) 1996-07-02
IL122424A0 (en) 1998-06-15
SI9620077A (sl) 1998-08-31
WO1996040652A1 (en) 1996-12-19
NZ309648A (en) 1998-09-24
TW358091B (en) 1999-05-11
SK164397A3 (en) 2000-04-10
CA2223391A1 (en) 1996-12-19
AU704535B2 (en) 1999-04-29
LV12045A (lv) 1998-05-20
HUP9900913A2 (hu) 1999-09-28
EP0837855A1 (en) 1998-04-29
MX9709652A (es) 1998-03-29
EE9700330A (et) 1998-06-15
LT4381B (lt) 1998-09-25

Similar Documents

Publication Publication Date Title
PL317929A1 (en) Pyrido-condenset thenyl- and furanyl oxazolydinones, method of obtaining and drugs containing them
PL323993A1 (en) Method of obtaining n-monosubstituted and n,n-disubstituted dissymmetrical cyclic ureas
PL342207A1 (en) Derivatives of cyclic amines and their application as drugs
PL314635A1 (en) Derivatives of pyrimidinodione, pyrimidinotrione, triazinodione and tetrahydroquinazolinodione and method of obtaining them
GR3029893T3 (en) N-(Benzofuranazyl)-arylsulphonamides and their analogues useful as endothelin-receptor-antagonists
PL334337A1 (en) Derivatives of sulphonamides, method of obtaining them and their application as drugs
PL319050A1 (en) 2-aryl-substituted pyridines, method of obtaining and drugs containing them
PL338143A1 (en) Derivatives acylpiperazinylpyrimidines, method of obtaining and drugs containing them
FI945166A0 (fi) Katalyttejä, niiden käyttömenetelmä ja menetelmä niiden valmistamiseksi
PL312270A1 (en) Novel derivatives of indolopiperidine, method of obtaining them and pharmaceutical preparation and method of obtaining same
PL316816A1 (en) Derivatives of purin-6-one, method of obtaining them and drugs containing such derivatives
HUP0004332A3 (en) 1,3-disubstituted ureas as acat inhibitors, and method of preparing thereof
PL344887A1 (en) Method of correcting cannon's dynamic errors and apparatus therefor
ZA94441B (en) An application and method for the production of N-cyclic and N,N'-dicyclic ureas
IL122457A0 (en) Method for preparing n,n'-disubstituted cyclic ureas
ZA98825B (en) Method of using neurotrophic carbamates and ureas
AU5168496A (en) Butyryl-tyrosinyl spermine, analogs thereof and methods of preparing and using same
PL312546A1 (en) Phenylocyclohexylocarboxylic amides, method of obtaining them and drugs containing such amides
PL330899A1 (en) Novel synthetic catechol derivatives, method of obtaining them and their application
PL325413A1 (en) Novel 1-arylalkyl imidazolyn-2-ones of anticonvulsive action containing disubstituted amino radical at their fourth position and method of obtaining them
PL322160A1 (en) Method of obtaining prostaglansins e1, e2 and their analogues using fluorylocuprous reagents
PL317562A1 (en) Method of obtaining nitrones and method obtaining n-monosubstituted hydroxylamines
PL312209A1 (en) Novel compounds of seccomacrolydes and seccoazalydes class, intermediate compounds and method of obtaining them
PL308946A1 (en) Method of obtaining 3-aminoisoquinoline and its n-mono- and n,n-disubstituted derivatives
ZA935214B (en) Method of lengthening and thickening human hair